These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 11057405)
21. Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP. De Klerk JM; Zonnenberg BA; Blijham GH; Van Het Schip AD; Hoekstra A; Han SH; Quirijnen JM; Van Dijk A; Van Rijk PP Anticancer Res; 1997; 17(3B):1773-7. PubMed ID: 9179233 [TBL] [Abstract][Full Text] [Related]
22. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP. Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380 [TBL] [Abstract][Full Text] [Related]
23. Serum hemoglobin levels predict response to strontium-89 and rhenium-186-HEDP radionuclide treatment for painful osseous metastases in prostate cancer. van der Poel HG; Antonini N; Hoefnagel CA; Horenblas S; Valdes Olmos RA Urol Int; 2006; 77(1):50-6. PubMed ID: 16825816 [TBL] [Abstract][Full Text] [Related]
24. Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases. Palmedo H; Bender H; Dierke-Dzierzon C; Carl UM; Risse J; Krebs D; Biersack HJ Clin Nucl Med; 1999 Sep; 24(9):643-8. PubMed ID: 10478737 [TBL] [Abstract][Full Text] [Related]
25. [Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)]. Holle LH; Humke U; Trampert L; Ziegler M; Kirsch CM; Oberhausen E Urologe A; 1997 Nov; 36(6):540-7. PubMed ID: 9487590 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases. Liepe K; Kotzerke J Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384 [TBL] [Abstract][Full Text] [Related]
27. 186Re-HEDP for metastatic bone pain in breast cancer patients. Lam MG; de Klerk JM; van Rijk PP Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S162-70. PubMed ID: 15118846 [TBL] [Abstract][Full Text] [Related]
28. [Radionuclide therapy for bone metastases by drugs based on Re-188]. Liepe K; Krylov VV; Kochetova TY Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946 [TBL] [Abstract][Full Text] [Related]
29. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast. Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634 [TBL] [Abstract][Full Text] [Related]
30. Phase 1 study of rhenium-186-HEDP in patients with bone metastases originating from breast cancer. de Klerk JM; van het Schip AD; Zonnenberg BA; van Dijk A; Quirijnen JM; Blijham GH; van Rijk PP J Nucl Med; 1996 Feb; 37(2):244-9. PubMed ID: 8667053 [TBL] [Abstract][Full Text] [Related]
31. Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors. Iakovou I; Doumas A; Badiavas K; Mpalaris V; Frangos S; Farmakis G Cancer Biother Radiopharm; 2014 Apr; 29(3):116-23. PubMed ID: 24392878 [TBL] [Abstract][Full Text] [Related]
32. Rhenium-188 HEDP to treat painful bone metastases. Li S; Liu J; Zhang H; Tian M; Wang J; Zheng X Clin Nucl Med; 2001 Nov; 26(11):919-22. PubMed ID: 11595844 [TBL] [Abstract][Full Text] [Related]
33. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review. Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636 [TBL] [Abstract][Full Text] [Related]
34. Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Liepe K; Hliscs R; Kropp J; Runge R; Knapp FF; Franke WG J Nucl Med; 2003 Jun; 44(6):953-60. PubMed ID: 12791825 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer. Kolesnikov-Gauthier H; Carpentier P; Depreux P; Vennin P; Caty A; Sulman C J Nucl Med; 2000 Oct; 41(10):1689-94. PubMed ID: 11037999 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow absorbed dose of rhenium-186-HEDP and the relationship with decreased platelet counts. de Klerk JM; van Dieren EB; van het Schip AD; Hoekstra A; Zonnenberg BA; van Dijk A; Rutgers DH; Blijham GH; van Rijk PP J Nucl Med; 1996 Jan; 37(1):38-41. PubMed ID: 8543998 [TBL] [Abstract][Full Text] [Related]
37. Palliative therapy with rhenium-186-HEDP for bone metastases of breast cancer. Guerra UP; Englaro E; Cattaruzzi E Tumori; 1997; 83(2):560-2. PubMed ID: 9226021 [No Abstract] [Full Text] [Related]
38. 89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma. Baczyk M; Czepczyński R; Milecki P; Pisarek M; Oleksa R; Sowiński J Nucl Med Commun; 2007 Apr; 28(4):245-50. PubMed ID: 17325585 [TBL] [Abstract][Full Text] [Related]
39. Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients. Zhang H; Tian M; Li S; Liu J; Tanada S; Endo K Cancer Biother Radiopharm; 2003 Oct; 18(5):719-26. PubMed ID: 14629820 [TBL] [Abstract][Full Text] [Related]
40. Application of rhenium-188 HEDP in bone metastases therapy. Scheffler J; Derejko M; Bandurski T; Romanowicz G Nucl Med Rev Cent East Eur; 2003; 6(1):55-7. PubMed ID: 14600935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]